ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $3.61 and traded as high as $5.25. ZIVO Bioscience shares last traded at $5.00, with a volume of 2,015 shares changing hands.
ZIVO Bioscience Trading Up 19.0%
The firm has a fifty day moving average of $3.61 and a 200 day moving average of $6.53. The company has a market capitalization of $20.76 million, a P/E ratio of -1.02 and a beta of 0.10.
ZIVO Bioscience Company Profile
ZIVO Bioscience is a clinical-stage biotechnology company focused on developing precision live biotherapeutics to prevent and treat gastrointestinal infections in both animal and human health markets. The company applies synthetic biology, microbiology and fermentation technologies to engineer proprietary bacterial strains that produce targeted lactic acid and antimicrobial compounds. Its pipeline includes ZB-01, an orally administered therapy for recurrent Clostridioides difficile infections in humans, and ZB-02, a feed-additive candidate aimed at reducing Salmonella colonization in poultry.
Founded in 2016 and headquartered in Carlsbad, California, ZIVO Bioscience leverages exclusive licensing agreements with academic institutions to advance its lead programs through preclinical and early clinical development.
Featured Stories
- Five stocks we like better than ZIVO Bioscience
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
